These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19361412)

  • 1. [Colorectal cancer screening programme in France, role of the National Institute of Cancer].
    Viguier J; Nathan Mle Q
    Med Sci (Paris); 2009 Mar; 25 Spec No 1():45-52. PubMed ID: 19361412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. French colorectal cancer screening pilot programme: results of the first round.
    Goulard H; Boussac-Zarebska M; Ancelle-Park R; Bloch J
    J Med Screen; 2008; 15(3):143-8. PubMed ID: 18927097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004.
    Malila N; Anttila A; Hakama M
    J Med Screen; 2005; 12(1):28-32. PubMed ID: 15814016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
    Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
    Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [French screening program of breast cancer. Results from 5 districts (1989-1994)].
    Séradour B; Allemand H; Schaffer P
    Bull Cancer; 1997 Aug; 84(8):822-8. PubMed ID: 9339188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
    Malila N; Oivanen T; Hakama M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evidence-based planning: the case of mass screening for colorectal cancer in the Lazio region of Italy].
    Federici A; Borgia P; Guasticchi G
    Ann Ig; 2005; 17(4):313-22. PubMed ID: 16156391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based breast cancer screening: policy advice for a New Zealand screening programme. Breast Cancer Screening Policy Advisory Group.
    N Z Med J; 1998 Apr; 111(1064):138-42. PubMed ID: 9612474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on population screening for colorectal cancer in New Zealand. Members of the National Health Committee Working Party on Population Screening for Colorectal Cancer.
    N Z Med J; 1999 Jan; 112(1080):4-6. PubMed ID: 10073156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district].
    Giorgi R; Reynaud J; Wait S; Seradour B
    Bull Cancer; 2005 Nov; 92(11):995-1001. PubMed ID: 16316834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast, cervical and colo-rectal simultaneous mass screening program for women 50 to 69 years old in Isere].
    Garnier A; Exbrayat C; Marron J; Seigneurin D; Winckel P; Bolla M
    Sante Publique; 2000 May; 12 Spec No():59-69. PubMed ID: 10989629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for population colorectal cancer screening in New Zealand.
    Parry S; Richardson A; Green T; Marshall B; Bissett I; Bloomfield A; Chadwick V; Cunningham C; Findlay M; Greer B; McMenamin J; Strid J; Robertson G; Teague C
    N Z Med J; 2007 Jul; 120(1258):U2633. PubMed ID: 17653251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme.
    Nnoaham KE; Lines C
    Gut; 2008 Sep; 57(9):1238-45. PubMed ID: 18441004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening.
    Yeoh KG; Chew L; Wang SC
    J Med Screen; 2006; 13 Suppl 1():S14-9. PubMed ID: 17227636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain).
    Peris M; Espinàs JA; Muñoz L; Navarro M; Binefa G; Borràs JM;
    J Med Screen; 2007; 14(2):81-6. PubMed ID: 17626707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon cancer screening and surveillance controversies.
    Lieberman D
    Curr Opin Gastroenterol; 2009 Sep; 25(5):422-7. PubMed ID: 19465849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in screening for colorectal cancer--United States, 1997 and 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Mar; 50(9):162-6. PubMed ID: 11393486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.